GLP-1 Market
LLY $1136.11 ▼ -0.2% NVO $42.53 ▼ -2.1% PFE $27.55 ▼ -0.6% VKTX $29.95 ▼ -5.0% KLRA $13.45 ▼ -2.2% GPCR $38.95 ▲ +1.3% RHHBY $54.90 ▲ +0.2%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Insulin Degludec

Company
The United Bio-Technology (Hengqin) Co., Ltd.
Mechanism
Mechanism not yet reported
Route
Injectable
Recruiting trials
9 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

9 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 16, 2026

Find a Clinical Trial Near Me

See recruiting studies for Insulin Degludec and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT03463564

    Insulin Pump vs Multiple Daily Injections of Insulin and Glyco-metabolic Control in Type 1 Diabetic Patients

    Not yet reported University of Campania Luigi Vanvitelli 150 participants Est. completion 2026-12 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Recruiting NCT NCT06280703

    A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)

    Not yet reported Eli Lilly and Company 118 participants Est. completion 2026-09 1 site
    Other conditions: Healthy, Type 1 Diabetes Mellitus
    View official trial listing →
  • Recruiting NCT NCT06945406

    A Study of LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 Diabetes

    Not yet reported Eli Lilly and Company 124 participants Est. completion 2026-12 1 site
    Type 2 diabetes Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Recruiting NCT NCT07032688

    A Clinical Study to Evaluate the Pharmacokinetic and Pharmacodynamics Properties of of SHR-3167 in Subjects With Type 2 Diabetes

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 55 participants Est. completion 2027-04 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Recruiting NCT NCT07146347

    Comparison Study of Insulin GZR4 With Insulin Degludec

    Not yet reported Gan and Lee Pharmaceuticals, USA 14 participants Est. completion 2026-06-01 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Recruiting NCT NCT07242664

    Clamp Study to Estimate the Relative Potency of GZR33 Versus Insulin Degludec at Steady State

    Not yet reported Gan and Lee Pharmaceuticals, USA 12 participants Est. completion 2026-04-15 2 sites Stand-alone
    Other conditions: Type 1 Diabetes Mellitis
    View official trial listing →
  • Recruiting NCT NCT07376200

    Single-ascending Dose Study of HEC-151 Injection

    Not yet reported Sunshine Lake Pharma Co., Ltd. 81 participants Est. completion 2026-09-27 2 sites
    Other conditions: Healthy Adult Male
    View official trial listing →
  • Recruiting NCT NCT07527078

    Evaluate the Efficacy and Safety of GZR33 Injection in Patients With Type 2 Diabetes

    Not yet reported Gan & Lee Pharmaceuticals. 350 participants Est. completion 2027-04-17 1 site
    Type 2 diabetes
    View official trial listing →
  • Recruiting NCT NCT07630233

    A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Subcutaneous UBT38006 Injection in Healthy Adult Males

    Not yet reported The United Bio-Technology (Hengqin) Co., Ltd. 53 participants Est. completion 2026-10-25 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00611884

    Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 245 participants Est. completion 2008-08 29 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00612040

    Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Insulin Aspart in Subjects With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 178 participants Est. completion 2008-06 33 sites Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00613951

    Comparison of Two NN5401 Formulations Versus Biphasic Insulin Aspart 30, All in Combination With Metformin in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 182 participants Est. completion 2008-08 31 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00614055

    Comparison of Two NN5401 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 178 participants Est. completion 2008-07 28 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00841087

    Comparison of NN1250 Versus Insulin Detemir, Both Combined With Insulin Aspart in Subjects With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 65 participants Est. completion 2009-05 8 sites Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00842361

    Comparison of NN5401 Versus Biphasic Insulin Aspart 30 on a Twice Daily Regimen in Subjects With Type 2 Diabetes Mellitus

    Not yet reported Novo Nordisk A/S 66 participants Est. completion 2009-06 8 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00961324

    A Trial Investigating the Within-subject Variability of NN1250 in Subjects With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 54 participants Est. completion 2009-10-26 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00964418

    A Trial Investigating the Effect of NN1250 in Young and Elderly Subjects With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 27 participants Est. completion 2009-11 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00964964

    A Trial Assessing Changes in Blood Sugar and the Number of Periods Where Supplementation of Carbohydrate is Needed to Treat Low Blood Sugar, During Two Different Treatment Regimens of NN1250 in Type 1 Diabetics

    Not yet reported Novo Nordisk A/S 18 participants Est. completion 2009-09 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00966368

    Comparison of Two NN1250 Formulations in Healthy Volunteers

    Not yet reported Novo Nordisk A/S 27 participants Est. completion 2009-10 1 site Stand-alone
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT00972283

    Comparison of NN1250 With Insulin Glargine Plus Insulin Aspart With/Without Metformin and With/Without Pioglitazone in Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 1006 participants Est. completion 2010-10-28 136 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00976326

    A Trial Investigating the Pharmacokinetic (Mode of Action in the Body) and Safety Profiles of NN1250 (Insulin Degludec) in Subjects With Various Degrees of Impaired Liver Function and in Subjects With Normal Liver Function

    Not yet reported Novo Nordisk A/S 12 participants Est. completion 2010-03 1 site Stand-alone
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT00978627

    Comparison of NN5401 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 548 participants Est. completion 2010-05 81 sites Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00982228

    Comparison of NN1250 Plus Insulin Aspart With Insulin Glargine Plus Insulin Aspart in Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 629 participants Est. completion 2010-11-08 91 sites Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00982644

    Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 1030 participants Est. completion 2010-12 187 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00983021

    Safety and Tolerability of NN9068 in Healthy Male Volunteers

    Not yet reported Novo Nordisk A/S 24 participants Est. completion 2009-12 1 site Mixed
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT00992537

    Comparison of the Effect of NN5401 With the Effect of NN1250 and Insulin Aspart in Type 1 Diabetics

    Not yet reported Novo Nordisk A/S 27 participants Est. completion 2010-01 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00993096

    Investigation of the Response Relationship of NN5401 in Type 1 Diabetics

    Not yet reported Novo Nordisk A/S 33 participants Est. completion 2009-12 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01002768

    Comparison of Hypoglycaemic Response Between NN1250 and Insulin Glargine in Type 1 Diabetics

    Not yet reported Novo Nordisk A/S 28 participants Est. completion 2010-03 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01006057

    A Trial Investigating the NN1250 Concentration-time Curve in Subjects With Various Degrees of Renal Impairment and in Subjects With Normal Renal Function

    Not yet reported Novo Nordisk A/S 32 participants Est. completion 2010-05 1 site Stand-alone
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT01006291

    Comparison of NN1250 With Insulin Glargine in Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 687 participants Est. completion 2010-09 72 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01009580

    Comparison of NN5401 With Biphasic Insulin Aspart 30 in Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 447 participants Est. completion 2010-08-23 53 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01030926

    A Trial Investigating the Concentration in the Blood of NN1250 in Children, Adolescents and Adults With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 39 participants Est. completion 2010-05 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01043510

    The Effect of NN1250 in Subjects With Type 2 Diabetes of Different Race and/or Ethnic Origin

    Not yet reported Novo Nordisk A/S 63 participants Est. completion 2010-10 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01045447

    Comparison of NN5401 With Insulin Glargine, Both in Combination With Oral Antidiabetic Drugs, in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 465 participants Est. completion 2010-10 65 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01045707

    Comparison of NN5401 Versus Insulin Glargine, Both Combined With Metformin Treatment, in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 530 participants Est. completion 2010-10 92 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01046110

    Comparison of NN1250 With Sitagliptin in Subjects With Type 2 Diabetes Never Treated With Insulin

    Not yet reported Novo Nordisk A/S 458 participants Est. completion 2010-11 93 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01051102

    Effect of NN5401 in Japanese Subjects With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 21 participants Est. completion 2010-04 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01059799

    Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 435 participants Est. completion 2010-12-16 53 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01059812

    A Pan Asian Trial Comparing Efficacy and Safety of NN5401 and Biphasic Insulin Aspart 30 in Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 424 participants Est. completion 2010-12-23 46 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01068665

    Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 460 participants Est. completion 2010-11 116 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01068678

    Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 460 participants Est. completion 2010-11 99 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01074268

    Comparison of NN1250 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 456 participants Est. completion 2010-12 69 sites Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01076634

    Comparison of Two NN1250 Formulations in Subjects With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 33 participants Est. completion 2010-07 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01076647

    Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 467 participants Est. completion 2010-12 105 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01079234

    Comparison of NN1250 With Insulin Glargine in Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 493 participants Est. completion 2011-05 82 sites Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01114542

    A Trial Evaluating the Effect of NN1250 at Steady State Conditions in Subjects With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 66 participants Est. completion 2010-08-10 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01125553

    A Comparison Between Two Formulations of NN5401 in Healthy Subjects

    Not yet reported Novo Nordisk A/S 26 participants Est. completion 2010-08 1 site Stand-alone
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT01134224

    A Trial Investigating the Effect of NN5401 in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 39 participants Est. completion 2010-11 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01135927

    A Trial Investigating the Effect of NN1250 in Japanese Subjects With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 22 participants Est. completion 2010-10 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01135992

    Switching From Insulin Glargine to Insulin Degludec in Subjects With Type 2 Diabetes Mellitus (BEGIN™)

    Not yet reported Novo Nordisk A/S 143 participants Est. completion 2010-11 27 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01138488

    A Trial Investigating the Total Exposure of NN5401 (Insulin Degludec/Insulin Aspart) in Children, Adolescents and Adult Subjects With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 38 participants Est. completion 2010-11 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01151072

    A Trial Comparing the Effect of NN1250 After Different Routes of Injection in Healthy Subjects

    Not yet reported Novo Nordisk A/S 20 participants Est. completion 2010-10 1 site Stand-alone
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT01154881

    A Trial Evaluating the Blood Glucose-lowering Effect of NN1250 in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 49 participants Est. completion 2010-11 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01173926

    Comparison of the Effect of NN5401 With the Effect of NN1250 and Insulin Aspart in Subjects With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 27 participants Est. completion 2010-11 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01174303

    A Trial Investigating the Exposure of NN5401 in Young Adults and Elderly Subjects With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 28 participants Est. completion 2010-11 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01193387

    Comparison of Two Identical NN1250 Formulations in Healthy Volunteers

    Not yet reported Novo Nordisk A/S 26 participants Est. completion 2010-11 1 site Stand-alone
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT01272193

    Comparison of NN5401 With Insulin Glargine in Insulin Naive Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 296 participants Est. completion 2011-09 50 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01319240

    Safety and Tolerability of Insulin Degludec/Liraglutide (A3) in Healthy Subjects

    Not yet reported Novo Nordisk A/S 24 participants Est. completion 2011-05 1 site Stand-alone
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT01326026

    Comparing the Efficacy and Safety of NN1250 Once Daily When Titrated Using 2 Different Algorithms in Insulin naïve Subjects With Type 2 Diabetes Mellitus

    Not yet reported Novo Nordisk A/S 222 participants Est. completion 2011-12 45 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01336023

    Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 1663 participants Est. completion 2012-11-22 302 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01364428

    Comparison of Two Insulin Degludec Formulations in Subjects With Type 2 Diabetes Mellitus

    Not yet reported Novo Nordisk A/S 373 participants Est. completion 2012-01 45 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01365507

    Efficacy and Safety of Insulin Degludec/Insulin Aspart in Insulin-naïve Subjects With Type 2 Diabetes Using Two Dosing Regimens

    Not yet reported Novo Nordisk A/S 276 participants Est. completion 2012-04 42 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01388361

    Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin

    Not yet reported Novo Nordisk A/S 413 participants Est. completion 2012-07 124 sites Mixed
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01392573

    A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 413 participants Est. completion 2012-10-04 86 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01437592

    Investigating the Pharmacokinetic Properties of NN1250 in Healthy Chinese Subjects

    Not yet reported Novo Nordisk A/S 24 participants Est. completion 2011-11-22 1 site Stand-alone
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT01455142

    A Trial to Test for Bioequivalence Between NN1045 and NN5401 in Subjects With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 32 participants Est. completion 2012-01 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Terminated NCT NCT01467414

    A Trial Investigating the Effect of NN1250 in Japanese Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 1 participants Est. completion 2011-12 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01513473

    A Trial Investigating the Efficacy and Safety of Insulin Degludec in Children and Adolescents With Type 1 Diabetes Mellitus

    Not yet reported Novo Nordisk A/S 350 participants Est. completion 2013-07-30 81 sites Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01513590

    A Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Insulin naïve Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 394 participants Est. completion 2012-11-19 49 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01569841

    A Trial Comparing the Efficacy of Insulin Degludec With Insulin Glargine on Glycaemic Control Using Continuous Glucose Monitoring in Patients With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 24 participants Est. completion 2012-11 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01570751

    A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin

    Not yet reported Novo Nordisk A/S 145 participants Est. completion 2014-01 46 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01590836

    A Trial Investigating the Pharmacodynamic Properties of NN5401 in Subjects With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 22 participants Est. completion 2012-06 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01618162

    The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy

    Not yet reported Novo Nordisk A/S 435 participants Est. completion 2013-10-23 87 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01623375

    A Trial Investigating the Absolute Bioavailability of Insulin Degludec in Healthy Subjects

    Not yet reported Novo Nordisk A/S 18 participants Est. completion 2012-08 1 site Stand-alone
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT01664247

    The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification

    Not yet reported Novo Nordisk A/S 346 participants Est. completion 2013-12-31 132 sites Added to GLP-1
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01676116

    The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy

    Not yet reported Novo Nordisk A/S 438 participants Est. completion 2014-03-11 109 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01680341

    Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine

    Not yet reported Novo Nordisk A/S 272 participants Est. completion 2013-08-22 45 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01704417

    A Trial Comparing the Effect of Exercise on Blood Glucose in Subjects With Type 1 Diabetes, Who Are Treated With Either Insulin Degludec or Insulin Glargine

    Not yet reported Novo Nordisk A/S 40 participants Est. completion 2013-03 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01713530

    A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin

    Not yet reported Novo Nordisk A/S 274 participants Est. completion 2014-01-09 51 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01773798

    A Trial Investigating the Pharmacodynamic and Pharmacokinetic Properties of Insulin Degludec/Insulin Aspart 15 in Subjects With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 33 participants Est. completion 2013-08 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01814137

    A Randomised Trial Comparing Efficacy and Safety After Intensification With Either Insulin Aspart Once Daily as add-on or Changing to Basal Bolus Treatment With Insulin Degludec and Insulin Aspart in Subjects With Type 2 Diabetes Previously Treated With Insulin Degludec/Insulin Aspart Twice Daily

    Not yet reported Novo Nordisk A/S 40 participants Est. completion 2014-03 40 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01835431

    A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus

    Not yet reported Novo Nordisk A/S 362 participants Est. completion 2014-11-07 73 sites Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01849289

    A Trial Comparing Efficacy and Safety of Insulin Degludec and Insulin Glargine in Insulin naïve Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 833 participants Est. completion 2014-05-15 81 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01865279

    Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Explorative Formulation of Insulin Degludec

    Not yet reported Novo Nordisk A/S 64 participants Est. completion 2006-04 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01865292

    Comparing the Pharmacodynamics and Pharmacokinetics of Explorative Formulation of Insulin Degludec With Insulin Glargine in Subjects With Type 1 and Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 40 participants Est. completion 2006-11 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01865305

    Comparison of Explorative Formulation of Insulin Degludec and Insulin Aspart Co-formulation Versus Explorative Formulation of Insulin Degludec and Insulin Aspart Separately Compared With Biphasic Insulin Aspart 30 in Male Subjects With Diabetes

    Not yet reported Novo Nordisk A/S 59 participants Est. completion 2007-02 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01865318

    Investigation of Pharmacodynamic Characteristics of Explorative Formulation of Insulin Degludec in Male Subjects With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 36 participants Est. completion 2007-01 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01865331

    Safety, Tolerability and Pharmacokinetic and Pharmacodynamic Characteristics of Explorative Formulations of Insulin Degludec and IDegAsp 50 in Healthy Japanese Subjects

    Not yet reported Novo Nordisk A/S 32 participants Est. completion 2007-03 1 site Stand-alone
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT01868529

    Comparison of Insulin Degludec With Insulin Glargine in Subjects With Type 1 Diabetes Mellitus

    Not yet reported Novo Nordisk A/S 63 participants Est. completion 2008-06 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01868555

    Safety, Pharmacokinetics and Pharmacodynamics of Two IDegAsp (One Explorative) Preparations and Two Insulin Degludec (One Explorative) Preparations in Japanese Subjects

    Not yet reported Novo Nordisk A/S 32 participants Est. completion 2008-02 1 site Stand-alone
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT01868568

    Comparison of IDegAsp (Inclusive Three Explorative Formulations) With Insulin Degludec and Insulin Aspart Separately Injected in Subjects With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 55 participants Est. completion 2008-08 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01868581

    Bioequivalence Between Two Explorative Insulin Degludec Formulations and Between Two Explorative IDegAsp Formulations in Healthy Subjects

    Not yet reported Novo Nordisk A/S 58 participants Est. completion 2008-08 1 site Stand-alone
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT01880736

    A Trial Investigating the Efficacy and Safety of Flexible vs. Fixed Dosing and Simple vs. Stepwise Titration With Once Daily (OD) Insulin Degludec in Inadequately Treated Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 458 participants Est. completion 2014-04 40 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01916174

    A Trial to Demonstrate Bioequivalence Between Two Insulin Degludec/Liraglutide Formulations, B5 and V2 in Healthy Subjects

    Not yet reported Novo Nordisk A/S 50 participants Est. completion 2013-11 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT01952145

    A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus

    Not yet reported Novo Nordisk A/S 557 participants Est. completion 2014-11-04 91 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01959529

    A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Events

    Not yet reported Novo Nordisk A/S 7637 participants Est. completion 2016-10-16 446 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01984372

    Post-marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Tresiba®

    Novo Nordisk A/S 6163 participants Est. completion 2019-04-30 1 site
    Type 2 diabetes Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT02030600

    A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 721 participants Est. completion 2015-12-04 166 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT02033889

    A Study To Evaluate The Efficacy And Safety Of Ertugliflozin In Participants With Type 2 Diabetes Mellitus And Inadequate Glycemic Control On Metformin Monotherapy (MK-8835-007).

    Not yet reported Merck Sharp & Dohme LLC 621 participants Est. completion 2017-08-03
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02034513

    A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, Both With Insulin Aspart as Mealtime Insulin in Subjects With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 501 participants Est. completion 2016-01-11 99 sites Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT02100475

    A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Increase With Insulin Degludec/Liraglutide in Subjects With Type 2 Diabetes Mellitus, Previously Treated With Insulin Degludec/Liraglutide and Metformin and in Need of Further Intensification

    Not yet reported Novo Nordisk A/S 31 participants Est. completion 2015-04 60 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT02117622

    A Non-interventional, Post Marketing Surveillance (PMS) Study of Tresiba® (Insulin Degludec) to Evaluate Long Term Safety and Efficacy in Patients With Diabetes Mellitus in Routine Clinical Practice in India

    Novo Nordisk A/S 1056 participants Est. completion 2017-04-05 38 sites
    Type 2 diabetes Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT02148861

    A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneously Administered NNC0148-0287 (Insulin 287) in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 49 participants Est. completion 2015-06-01 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT02192450

    Insulin Degludec and Symptomatic Nocturnal Hypoglycaemia

    Not yet reported Nordsjaellands Hospital 149 participants Est. completion 2019-02-28 1 site Stand-alone
    Other conditions: Type 1 Diabetes Mellitus, Nocturnal Hypoglycemia, Recurrent Severe Hypoglycaemia
    View official trial listing →
  • Completed NCT NCT02230618

    Post Marketing Surveillance (PMS) Study of Ryzodeg™ (Insulin Degludec/Insulin Aspart) in Patients With Diabetes Mellitus in Routine Clinical Practice in India

    Novo Nordisk A/S 1029 participants Est. completion 2017-06-01 35 sites
    Type 2 diabetes Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT02298192

    A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms

    Not yet reported Novo Nordisk A/S 420 participants Est. completion 2015-12-23 84 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT02360254

    Effects of Shifting From Twice Daily Insulin Glargine or Detemir to Once Daily Insulin Degludec in Type 1 Diabetes

    University of Padova 26 participants Est. completion 2016-02 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02392117

    Investigating the Safety and Effectiveness of Insulin Degludec in a Real World Population With Type 1 and 2 Diabetes Mellitus

    Novo Nordisk A/S 1262 participants Est. completion 2018-03-19 8 sites
    Type 2 diabetes Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT02420262

    A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Basal-bolus Therapy in Subjects With Type 2 Diabetes Mellitus

    Not yet reported Novo Nordisk A/S 506 participants Est. completion 2016-10-05 117 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT02500706

    Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Adults With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 1108 participants Est. completion 2017-08-16 152 sites Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT02501161

    A 104 Week Clinical Trial Comparing Long Term Glycaemic Control of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine Therapy in Subjects With Type 2 Diabetes Mellitus

    Not yet reported Novo Nordisk A/S 1012 participants Est. completion 2018-10-03 143 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT02536859

    Comparing Pharmacodynamic and Pharmacokinetic Properties of Insulin Degludec and Insulin Glargine 300 U/mL at Steady-state Conditions in Subjects With Type 1 Diabetes Mellitus

    Not yet reported Novo Nordisk A/S 60 participants Est. completion 2016-04-14 1 site Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT02607306

    A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Japanese Subjects With Type 2 Diabetes Mellitus.

    Not yet reported Novo Nordisk A/S 819 participants Est. completion 2017-12-22 76 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT02648217

    Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart Twice Daily and Biphasic Insulin Aspart Twice Daily in Subjects With Type 2 Diabetes Mellitus Before, During and After Ramadan

    Not yet reported Novo Nordisk A/S 263 participants Est. completion 2016-09-05 32 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT02662114

    Investigating the Effectiveness of Tresiba® (Insulin Degludec) After Switching Basal Insulin in a Population With Type 1 or Type 2 Diabetes Mellitus

    Novo Nordisk A/S 2302 participants Est. completion 2016-08-12 7 sites
    Type 2 diabetes Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT02670915

    Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 834 participants Est. completion 2018-03-03 155 sites Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT02680457

    Effect of Insulin Degludec Versus Insulin Glargine on Glycemic Variability in Patients With Type 2 Diabetes Mellitus

    Not yet reported University of Guadalajara 12 participants Est. completion 2016-11 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02738151

    Efficacy and Safety of Toujeo® Versus Tresiba® in Insulin-Naive Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Oral Antihyperglycemic Drug(s) ± GLP-1 Receptor Agonist

    Not yet reported Sanofi 929 participants Est. completion 2017-08-15 158 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02754817

    A Study of the Effectiveness of Xultophy® (Insulin Degludec/Liraglutide) in an Adult Real-world Population With Type 2 Diabetes Mellitus

    Novo Nordisk A/S 611 participants Est. completion 2016-10-20 5 sites
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT02762578

    Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 543 participants Est. completion 2017-06-19 42 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Terminated NCT NCT02767596

    Evaluation of Lixisenatide Efficacy in Diabetes Mellitus Type 2 With Failure of Other GLP-1 Analog

    Not yet reported Laniado Hospital 2 participants Est. completion 2017-02-21 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02773368

    A Clinical Trial Comparing Glycaemic Control and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine (IGlar) as add-on Therapy to SGLT2i in Subjects With Type 2 Diabetes Mellitus

    Not yet reported Novo Nordisk A/S 420 participants Est. completion 2017-10-23 88 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT02779413

    A Study to Evaluate Safety and Effectiveness in Patients of All Age Groups Excluding Less Than 12 Months Old Infants With Diabetes Mellitus in Routine Clinical Practice in Korea

    Novo Nordisk A/S 3303 participants Est. completion 2019-06-24 44 sites
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT02821052

    Post-marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Ryzodeg®

    Novo Nordisk A/S 1355 participants Est. completion 2018-11-24 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT02844790

    A Trial Investigating the Pharmacokinetic Properties of Insulin Degludec/Insulin Aspart in Healthy Chinese Subjects

    Not yet reported Novo Nordisk A/S 24 participants Est. completion 2016-09-27 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02906917

    A 38 Week Trial Comparing Effect and Safety of Insulin Degludec/Insulin Aspart vs. Insulin Glargine Plus Insulin Aspart in Subjects With Type 2 Diabetes Treated With Basal Insulin With or Without Oral Antidiabetic Treatment in Need of Treatment Intensification

    Not yet reported Novo Nordisk A/S 532 participants Est. completion 2017-12-24 71 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT02911948

    A Double-blinded Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec Both in Combination With Metformin in Japanese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal or Pre-mix/Combination Insulin Therapy and Oral Anti-diabetic Drugs

    Not yet reported Novo Nordisk A/S 210 participants Est. completion 2017-11-22 38 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT02964104

    A Trial Investigating the Safety, Tolerability, Pharmacokinetics (the Exposure of the Trial Drug in the Body) and Pharmacodynamics (the Effect of the Investigated Drug on the Body) of Insulin 287 in Subjects With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 50 participants Est. completion 2017-12-12 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT02967211

    A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to "Standard of Care" Basal Insulin in Patients Already Using Basal Insulin

    Not yet reported Sanofi 609 participants Est. completion 2017-10-20 118 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02967224

    A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to "Standard of Care" Basal Insulins in Insulin Naïve Patients Initiating Insulin

    Not yet reported Sanofi 705 participants Est. completion 2017-10-16 128 sites
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT03001323

    Insulin Degludec for the Management of Patient With Recurrent Diabetic Ketoacidosis

    Not yet reported Hennepin Healthcare Research Institute 27 participants Est. completion 2020-09-25 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Withdrawn NCT NCT03070704

    Non-interventional, Post Marketing Surveillance Study of Xultophy™ (Insulin Degludec/Liraglutide) to Evaluate Long Term Safety and Efficacy in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in India

    Novo Nordisk A/S Est. completion 2019-08-16
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT03078478

    A Trial Comparing the Efficacy and Safety of Insulin Degludec and Insulin Glargine 300 Units/mL in Subjects With Type 2 Diabetes Mellitus Inadequately Treated With Basal Insulin With or Without Oral Antidiabetic Drugs

    Not yet reported Novo Nordisk A/S 1609 participants Est. completion 2019-03-04 229 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT03091712

    Insulin Degludec Titration Using Mobile Insulin Dosing System

    Not yet reported Glooko 240 participants Est. completion 2019-09-15 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03172494

    A Trial Comparing Insulin Degludec/Liraglutide, Insulin Degludec, and Liraglutide in Chinese Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs)

    Not yet reported Novo Nordisk A/S 720 participants Est. completion 2019-07-13 36 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT03175120

    A Trial Comparing Insulin Degludec/Liraglutide and Insulin Degludec in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Therapy and Metformin With or Without One Other Oral Antidiabetic Drug (OAD)

    Not yet reported Novo Nordisk A/S 453 participants Est. completion 2019-04-04 37 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT03214367

    A Study of LY900014 in Participants With Type 1 Diabetes

    Not yet reported Eli Lilly and Company 1392 participants Est. completion 2019-08-22 172 sites Stand-alone
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT03214380

    A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 Diabetes

    Not yet reported Eli Lilly and Company 933 participants Est. completion 2019-03-13 141 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT03244241

    Basal-bolus Insulin Therapy Versus Standard Therapy for the Inpatient Management of Type 2 Diabetes: the IDA2 Study

    Not yet reported Merete Bechmann Christensen 100 participants Est. completion 2018-04-01 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03268005

    Research Study Comparing a New Medicine "Fast-acting Insulin Aspart" to Another Already Available Medicine "NovoRapid"/"NovoLog" in People With Type 2 Diabetes

    Not yet reported Novo Nordisk A/S 1264 participants Est. completion 2019-01-29 167 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT03292185

    A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Compared With Insulin Degludec and Liraglutide in Healthy Chinese Subjects

    Not yet reported Novo Nordisk A/S 24 participants Est. completion 2018-01-02 1 site Added to GLP-1
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT03328845

    Impact on the Oxidative Stress of the Different Analogues of Insulin in People With Type 1 Diabetes. (Ineox Study)

    Not yet reported Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud 300 participants Est. completion 2021-11-20 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT03336528

    Insulin Degludec and Glargine U100 for Management of Hospitalized and Discharged Patients With Type 2 Diabetes

    Not yet reported Emory University 180 participants Est. completion 2021-03-01 4 sites
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT03349840

    Randomised Open Label Study of Insulin Degludec Versus Insulin Glargine U100 in Ramadan

    Not yet reported Weill Cornell Medical College in Qatar 273 participants Est. completion 2018-12-31 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03377699

    Research Study Comparing Insulin Degludec to Insulin Detemir, Together With Insulin Aspart, in Pregnant Women With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 225 participants Est. completion 2020-12-17 71 sites Stand-alone
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT03387787

    Evaluation of Glycaemic Control Using GlucoTab® With Insulin Degludec in Hospitalized Patients With Diabetes Mellitus Type 2

    Not yet reported, Not yet reported Insel Gruppe AG, University Hospital Bern 15 participants Est. completion 2020-01-30 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03400501

    Reducing the Risk of Metabolic Decompensation in Diabetic Adolescents by Supervised School Administration of Insulin

    Not yet reported Yale University 32 participants Est. completion 2021-06-07 1 site Stand-alone
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT03416855

    A Regulatory Post Marketing Surveillance (rPMS) Study of Ryzodeg® FlexTouch® (Insulin Degludec /Insulin Aspart) to Evaluate Safety and Effectiveness in Patients With Diabetes Mellitus in Routine Clinical Practice in Korea

    Novo Nordisk A/S 768 participants Est. completion 2020-05-19 27 sites
    Type 2 diabetes Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT03497260

    Fructose in Exercising Individuals With Type 1 Diabetes Using Insulin Degludec

    Not yet reported Insel Gruppe AG, University Hospital Bern 15 participants Est. completion 2019-09-08 1 site
    Other conditions: Type 1 Diabetes Mellitus, Diabetes Complications
    View official trial listing →
  • Completed NCT NCT03557892

    Sensor-augmented Pump Versus Multiple Daily Injections With Degludec as Basal Insulin for Insulin Therapy in Type 1 Diabetes

    Not yet reported Azienda Ospedaliero-Universitaria Careggi 28 participants Est. completion 2020-01-02 1 site
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT03668808

    Comparison of Insulin Degludec With Insulin Glargine U100 for Adults With Type 1 Diabetes Crossing Multiple Time Zones.

    Not yet reported Sansum Diabetes Research Institute 25 participants Est. completion 2020-09-19 2 sites Stand-alone
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT03674866

    A Canadian Study of the Effectiveness of Tresiba® (Insulin Degludec) After Switching Basal Insulin in a Population With Type 1 or Type 2 Diabetes Mellitus

    Novo Nordisk A/S 662 participants Est. completion 2019-04-26 32 sites
    Type 2 diabetes Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT03687827

    A Research Study to Compare the Effect of Insulin Degludec and Insulin Glargine on Blood Sugar Levels in People With Type 2 Diabetes - the SWITCH PRO Study

    Not yet reported Novo Nordisk A/S 498 participants Est. completion 2019-12-27 67 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03726125

    A Study of LY3374849 in Healthy Participants

    Not yet reported Eli Lilly and Company 89 participants Est. completion 2019-09-27 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03736785

    A Study of LY3209590 in Participants With Type 2 Diabetes Mellitus

    Not yet reported Eli Lilly and Company 399 participants Est. completion 2020-02-18 44 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03737240

    IDegLira HIGH Trial

    Not yet reported Emory University 145 participants Est. completion 2022-07-08 2 sites
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT03740919

    A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 Diabetes

    Not yet reported Eli Lilly and Company 751 participants Est. completion 2021-07-02 111 sites
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT03745157

    RESILIENT: A Research Study, Looking at How Ryzodeg® Works in People With Type 2 Diabetes in Local Clinical Practice in Japan

    Novo Nordisk A/S 246 participants Est. completion 2019-10-29 29 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03785522

    A Research Study, Looking at How Tresiba® Works in People With Type 2 Diabetes in Local Clinical Practice in Saudi Arabia

    Novo Nordisk A/S 597 participants Est. completion 2020-11-30 21 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03823339

    A Research Study, Looking at How Xultophy® Works in People With Type 2 Diabetes in Local Clinical Practice in United Arab Emirates

    Novo Nordisk A/S 300 participants Est. completion 2020-12-14 3 sites
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT03838783

    Flexible Insulin Therapy Untethered Insulin Regimen in Avidly Exercising Patients With Type 1 Diabetes: FIT Untethered

    Not yet reported LMC Diabetes & Endocrinology Ltd. 30 participants Est. completion 2019-06-30 1 site Stand-alone
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT03862716

    Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IDegLira

    Not yet reported Population Health Research Institute 159 participants Est. completion 2023-07-31 8 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03882970

    A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes

    Not yet reported Eli Lilly and Company 1444 participants Est. completion 2021-01-04 122 sites
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT03908762

    mHealth Titration and Management

    Not yet reported Amalgam Rx, Inc. 40 participants Est. completion 2020-03 1 site
    Type 2 diabetes Other conditions: Diabetic Complication
    View official trial listing →
  • Completed NCT NCT03938740

    Comparison of Different Insulin Dosing Algorithms Using Hepatic Directed Vesicle-Insulin Lispro and Insulin Degludec

    Not yet reported Diasome Pharmaceuticals 61 participants Est. completion 2020-03-18 7 sites Stand-alone
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT03952130

    A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes

    Not yet reported Eli Lilly and Company 354 participants Est. completion 2022-01-10 30 sites Stand-alone
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT03952143

    A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 2 Diabetes

    Not yet reported Eli Lilly and Company 628 participants Est. completion 2021-01-20 41 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT03959865

    GLP-1 REceptor Agonists and Real World EvIdeNce

    University of Padova 6000 participants Est. completion 2019-05-31 6 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03987191

    Insulin Pump to Multiple Daily Injection Transition Clinical Trial

    Not yet reported University of Colorado, Denver 38 participants Est. completion 2020-10-08 1 site Stand-alone
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Status unknown NCT NCT04027023

    Evaluation of the Impact of Intensive Short-Term Drug Therapy in Patients With Type 2 Diabetes Mellitus

    Not yet reported Sciema UG 9 participants Est. completion 2021-05-31 2 sites
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT04034524

    Cardiovascular Outcomes and HbA1c Among Patients With Type 2 Diabetes Newly Initiating GLP1RAs vs Basal Insulin

    Brigham and Women's Hospital 20000 participants Est. completion 2020-12-31 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04042441

    A Research Study, Looking at How Ryzodeg® (Insulin Degludec/Insulin Aspart) Works in People With Type 2 Diabetes in Local Clinical Practice

    Novo Nordisk A/S 1122 participants Est. completion 2020-12-11 64 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04075513

    Comparison of Glucose Values and Variability Between TOUJEO and TRESIBA During Continuous Glucose Monitoring in Type 1 Diabetes Patients

    Not yet reported Sanofi 343 participants Est. completion 2021-09-16 7 sites
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT04190160

    Quality of Life and Fixed-ratio Combination of Insulin Degludec and Liraglutide (iDegLira)

    Not yet reported Stefano Rizza 35 participants Est. completion 2021-03-25 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04196231

    Durability of Combination of Insulin and GLP-1 Receptor Agonist or SGLT-2 Inhibitors Versus Basal Bolus Insulin Regimen in Type 2 Diabetes (BEYOND)

    Not yet reported University of Campania Luigi Vanvitelli 258 participants Est. completion 2020-10-20 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04227431

    A Research Study, Looking at How Tresiba® Works in People With Type 2 Diabetes in Local Clinical Practice in China

    Novo Nordisk A/S 938 participants Est. completion 2021-07-17 56 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04276428

    A Study of LY3209590 in Japanese Participants With Type 2 Diabetes Mellitus

    Not yet reported Eli Lilly and Company 28 participants Est. completion 2020-11-28 3 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04315688

    A Research Study, Looking at How Tresiba® Works in People With Type 2 Diabetes in Local Clinical Practice in Russia

    Novo Nordisk A/S 494 participants Est. completion 2021-08-02 40 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04409587

    Basal Insulin Glycemic ControL With DEglugec vs Aspart Via Pump

    Not yet reported Mountain Diabetes and Endocrine Center 59 participants Est. completion 2020-11-01 1 site
    Other conditions: Type1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT04450394

    A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes Mellitus

    Not yet reported Eli Lilly and Company 278 participants Est. completion 2021-10-08 64 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04450407

    A Study of LY3209590 in Participants With Type 1 Diabetes

    Not yet reported Eli Lilly and Company 266 participants Est. completion 2021-10-01 54 sites
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT04538352

    Transition From Basal/Bolus to Once-weekly Subcutaneous Semaglutide and Basal Insulin in Patients With T2D

    Not yet reported The Cleveland Clinic 60 participants Est. completion 2023-11-01 1 site Mixed
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04569994

    A Study to Look at the Safety of NNC0363-0845 in Healthy People and People With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 68 participants Est. completion 2021-06-23 1 site Stand-alone
    Other conditions: Healthy Volunteers, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT04585776

    A Study of LY900014 and Insulin Degludec in Participants With Type 1 Diabetes

    Not yet reported Eli Lilly and Company 31 participants Est. completion 2021-05-27 3 sites Stand-alone
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT04588259

    Research Study to Compare a New Medicine "Fast-acting Insulin Aspart" to Another Medicine "Insulin Aspart" in Chinese People With Diabetes

    Not yet reported Novo Nordisk A/S 331 participants Est. completion 2022-08-05 40 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT04623086

    Comparison of Glargine to Degludec Insulin Transition With or Without a Bridging Glargine Dose

    Not yet reported University of Washington 59 participants Est. completion 2023-12-31 1 site Stand-alone
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT04656106

    A Study Investigating the Clinical Parameters Associated With the Use of Ryzodeg® (Insulin Degludec/Insulin Aspart) in a Real-world Adult Population With Type 2 Diabetes in South Korea

    Novo Nordisk A/S 200 participants Est. completion 2021-07-01 6 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04663282

    A Trial of INS068 in Patients With Type 2 Diabetes Not Adequately Controlled With One or Two Oral Antidiabetics

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 179 participants Est. completion 2022-05-28 35 sites
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT04664764

    Intermediate and Long Acting Insulin Young Children Type 1 Diabetes.

    Not yet reported Ain Shams University 60 participants Est. completion 2021-03-10 1 site
    Other conditions: Type 1 Diabetes Mellitus With Hypoglycemia, type1diabetes
    View official trial listing →
  • Completed NCT NCT04666987

    A Research Study Looking at Long-term Blood Sugar Control in People With Type 2 Diabetes Being Treated With Xultophy® in a Real-world Setting in Italy

    Novo Nordisk A/S 359 participants Est. completion 2023-02-10 28 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04671043

    Caffeine Ingestion to Counter the Exercise-mediated Fall in Glycaemia in Type 1 Diabetes

    Not yet reported Insel Gruppe AG, University Hospital Bern 21 participants Est. completion 2023-02-02 1 site
    Other conditions: Caffeine and Carbohydrate, Carbohydrate Only, Placebo
    View official trial listing →
  • Completed NCT NCT04692415

    Insulin Glargine U300 vs Insulin Degludec U100 in Impact on the Glycaemic and Cardiovascular Factors

    Not yet reported University of Split, School of Medicine 25 participants Est. completion 2019-06-27 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04760626

    A Research Study to Compare a New Weekly Insulin, Insulin Icodec Used With DoseGuide App, and Daily Insulins in People With Type 2 Diabetes Who Have Not Used Insulin Before

    Not yet reported Novo Nordisk A/S 1085 participants Est. completion 2022-08-29 311 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04770532

    A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Use Daily Insulin

    Not yet reported Novo Nordisk A/S 526 participants Est. completion 2022-03-01 88 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04795531

    A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 3)

    Not yet reported Novo Nordisk A/S 588 participants Est. completion 2022-06-23 190 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04848480

    A Research Study to Compare a New Weekly Insulin, Insulin Icodec, and an Available Daily Insulin, Insulin Degludec, Both in Combination With Mealtime Insulin in People With Type 1 Diabetes (ONWARDS 6)

    Not yet reported Novo Nordisk A/S 582 participants Est. completion 2022-12-02 130 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT04892069

    Investigating the Effect of Ryzodeg® in Adult Patients With Type 2 Diabetes in Lebanon

    Novo Nordisk A/S 60 participants Est. completion 2021-11-18 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04952779

    Regulatory Post Marketing Surveillance (rPMS) Study of Xultophy® (Insulin Degludec/Liraglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea

    Novo Nordisk A/S 750 participants Est. completion 2024-12-15 32 sites
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT04955834

    A Clinical Study of Insulin Degludec Injection in Subjects With Type 2 Diabetes

    Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 344 participants Est. completion 2025-12-31 2 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT04965051

    Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T1DM

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 40 participants Est. completion 2023-12 1 site Stand-alone
    Other conditions: Type 1 Diabetes Mellitus With Diabetic Gastroparesis, HbA1c, Time in Range
    View official trial listing →
  • Completed NCT NCT04974528

    Afrezza® INHALE-1 Study in Pediatrics

    Not yet reported Mannkind Corporation 319 participants Est. completion 2025-04-29 39 sites Stand-alone
    Type 2 diabetes Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT05036876

    Degludec Glargine U300 Hospital Study

    Not yet reported Medanta, The Medicity, India 220 participants Est. completion 2022-03-01 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT05069545

    A Research Study Looking at How the Use of NovoPen® 6 for Treatment With Tresiba® & Fiasp® Affects the Blood Sugar Level in Patients With Type 1 Diabetes as Part of Local Clinical Practice

    Novo Nordisk A/S 411 participants Est. completion 2024-09-10 26 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Status unknown NCT NCT05103306

    Empagliflozin-based Quadruple Therapy vs Basal Insulin-based Therapy

    Chungbuk National University Hospital 300 participants Est. completion 2022-12
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT05161429

    BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes

    Brigham and Women's Hospital 550000 participants Est. completion 2024-06-30 5 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT05218915

    Basal Plus GLP1-ra on Glycemic Variability in CKD

    Not yet reported Elaine Chow 95 participants Est. completion 2024-10-30 1 site Added to GLP-1
    Chronic kidney disease Other conditions: Diabetes Mellitus
    View official trial listing →
  • Active, not recruiting NCT NCT05220917

    Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study

    Brigham and Women's Hospital 781430 participants Est. completion 2027-09-30 1 site
    Type 2 diabetes Other conditions: Cardiovascular Events, Renal Disease
    View official trial listing →
  • Completed NCT NCT05221580

    China Research of IDEgAsp Treatment in Real-world Clinical practicE (CREATE)

    Novo Nordisk A/S 887 participants Est. completion 2023-03-31 50 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT05243628

    Afrezza With Basal Combination (ABC): Afrezza® Combined With AID Pump or Insulin Degludec in Adults With Type 1 Diabetes

    Not yet reported Mannkind Corporation 33 participants Est. completion 2022-10-17 2 sites Stand-alone
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Status unknown NCT NCT05261997

    Endotherapy for Painless Chronic Pancreatitis

    Not yet reported Changhai Hospital 60 participants Est. completion 2023-11 1 site
    Other conditions: Pancreatitis, Chronic, Exocrine Pancreatic Insufficiency, Abdominal Pain, Cholangiopancreatography, Endoscopic Retrograde
    View official trial listing →
  • Completed NCT NCT05275400

    A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin

    Not yet reported Eli Lilly and Company 986 participants Est. completion 2024-05-15 127 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT05360537

    Effects of Degludec/Liraglutide on Time in Range, Inflammation and Endothelial Function vs Insulin Basal Bolus in Diabetic Inpatients

    Not yet reported University of Palermo 100 participants Est. completion 2022-04-20 1 site Added to GLP-1
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT05362058

    A Study of Insulin Efsitora Alfa (LY3209590) Compared to Degludec in Adults With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time

    Not yet reported Eli Lilly and Company 928 participants Est. completion 2024-04-10 113 sites
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT05413369

    iGlarLixi vs IDegAsp in Chinese Participants After OAD(s)

    Not yet reported Sanofi 582 participants Est. completion 2023-10-20 60 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT05417841

    Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T2DM

    Not yet reported Beijing Hospital 218 participants Est. completion 2025-08-15 7 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT05429359

    cArdiopulmonary exerCise Test Assessing Multiple biOmarkers and Hormones iN Type 1 diabetEs Under Different Circumstances

    Not yet reported University Hospital, Antwerp 50 participants Est. completion 2024-03-31
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT05434559

    Evaluation of Glycemic Control in Adults With Type 1 Diabetes When Switching to Insulin Degludec

    prof dr Pieter Gillard 475 participants Est. completion 2022-10-31 2 sites
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT05463744

    A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection Therapy

    Not yet reported Eli Lilly and Company 692 participants Est. completion 2024-05-07 83 sites
    Other conditions: Type 1 Diabetes, Diabetes
    View official trial listing →
  • Withdrawn NCT NCT05479591

    A Research Study Looking at Blood Sugar Control in People With Type 2 Diabetes Previously Treated With Premix Insulin and Initiating Treatment With Insulin Degludec/Liraglutide (IDegLira) in Local Clinical Practice in Croatia

    Novo Nordisk A/S Est. completion 2023-04-30
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT05545800

    Efficacy and Safety Of Different Regimens In Patients With Type 2 Diabetes Receiving Intensive Insulin Therapy

    Not yet reported Xiangya Hospital of Central South University 78 participants Est. completion 2024-06-01 1 site
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT05552859

    Gla-300 and IDeg-100 in Insulin-Naïve People With Type 2 Diabetes Mellitus and Renal Impairment

    Not yet reported Sanofi 62 participants Est. completion 2023-08-04 68 sites
    Type 2 diabetes Other conditions: Renal Impairment
    View official trial listing →
  • Completed NCT NCT05576298

    A Clinical Study Comparing the Pharmacokinetics and Pharmacodynamic Characteristics of Insulin Degludec Injection (RD15003) and Insulin Degludec Injection (Tresiba®) in Healthy Subjects

    Not yet reported Sunshine Lake Pharma Co., Ltd. 46 participants Est. completion 2022-03-21 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT05641337

    Research on Optimal Strategy of Hypoglycemic Therapy for Cirrhosis With Diabetes

    Not yet reported Huashan Hospital 184 participants Est. completion 2025-12-30 1 site Stand-alone
    Other conditions: Liver Cirrhosis, Diabetes
    View official trial listing →
  • Status unknown NCT NCT05767255

    Risk of Hypoglycemia in the Transition From Inpatient to Outpatient Setting. Comparative Study of Basal-bolus Insulin Versus Basal Insulin Plus GLP-1 Analogue

    Not yet reported Hospital Universitario San Ignacio 66 participants Est. completion 2023-08-30 1 site Added to GLP-1
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT05802862

    A Study of Insulin Degludec/Insulin Aspart Biosimilar (22011) Compared With Insulin Degludec/Insulin Aspart(Ryzodeg) in Participants With Type 2 Diabetes in China

    Not yet reported Sunshine Lake Pharma Co., Ltd. 414 participants Est. completion 2024-08-16 1 site Stand-alone
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT05904743

    INHALE-3: Afrezza® Combined With Insulin Degludec Versus Usual Care in Adults With Type 1 Diabetes

    Not yet reported Mannkind Corporation 141 participants Est. completion 2024-06-24 19 sites Stand-alone
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT06056167

    Degludec Insulin Use in Critically Ill Patients

    Not yet reported King Faisal Specialist Hospital & Research Center 155 participants Est. completion 2024-05-30 1 site Stand-alone
    Other conditions: Diabetes Mellitus, Critical Illness, Hyperglycemia
    View official trial listing →
  • Status unknown NCT NCT06057077

    Semaglutide GLP1 Agonists With Degludec Basal-bolus Insulin in Early Type 1 Diabetes to Basal-bolus

    Not yet reported, Not yet reported Ministry of Health, Saudi Arabia 120 participants Est. completion 2024-12-31
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT06111508

    The Effect and Safety of a Novel CGM-Based Titration Algorithm for Basal Insulin in T2DM Participants.

    Not yet reported University of Virginia 30 participants Est. completion 2024-09-16 2 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT06132126

    A Study to Investigate the Safety and Tolerability of LY3938577 in Healthy Participants and Participants With Type 2 Diabetes Mellitus

    Not yet reported Eli Lilly and Company 66 participants Est. completion 2024-06-28 3 sites
    Type 2 diabetes Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT06153537

    A Research Study in Saudi Arabia to Understand How the Dose Check App Used With Tresiba Treatment Helps to Control Blood Sugar Level

    Novo Nordisk A/S 179 participants Est. completion 2025-03-24 14 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT06178874

    Insulin Degludec vs Insulin Glargine for Glycemic Control in Critical Illness Hyperglycemia

    Not yet reported Ain Shams University 90 participants Est. completion 2024-06-01 1 site
    Other conditions: Glycemic Control, Insulin, Critical Illness
    View official trial listing →
  • Completed NCT NCT06199505

    A Trial Comparing Efficacy and Safety of GZR101 and IDegAsp in Insulin Naïve or Insulin Treated Subjects with T2DM

    Not yet reported Gan and Lee Pharmaceuticals, USA 153 participants Est. completion 2024-07-12 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT06202079

    A Trial Comparing the Efficacy and Safety of GZR4 Injection Versus Insulin Degludec in Subjects with Type 2 Diabetes Mellitus

    Not yet reported Gan and Lee Pharmaceuticals, USA 179 participants Est. completion 2024-08-08 8 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT06238778

    Phase 2b Trial Comparing HDV-Insulin Lispro to Insulin Lispro in Adults With Type 1 Diabetes Receiving Insulin Degludec

    Not yet reported Diasome Pharmaceuticals 227 participants Est. completion 2025-12-16 27 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT06288412

    A Study to Test How a New Long-acting Insulin Works in the Body of Patients With Type 2 Diabetes During Exercise and Prolonged Fasting

    Not yet reported Novo Nordisk A/S 30 participants Est. completion 2025-04-14 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT06408532

    The Efficacy and Safety of Insulin Degludec/Liraglutide Combination (IDegLira) in Patients With Type 2 Diabetes

    Not yet reported Peking University People's Hospital 256 participants Est. completion 2025-02-28
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT06449703

    A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide in Healthy Chinese Subjects

    Not yet reported Tonghua Dongbao Pharmaceutical Co.,Ltd 44 participants Est. completion 2024-06-16 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT06553248

    A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GZR4 in Subjects With Type 2 Diabetes

    Not yet reported Gan and Lee Pharmaceuticals, USA 36 participants Est. completion 2023-11-01 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT06556641

    A Clinical Study of GZR33 and GZR101 in Healthy Subjects

    Not yet reported Gan and Lee Pharmaceuticals, USA 28 participants Est. completion 2023-02-03 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Status unknown NCT NCT06559722

    A Trial Investigating the Efficacy and Safety of Insulin Degludec/Liraglutide Injection in Subjects With Type 2 Diabetes

    Not yet reported Tonghua Dongbao Pharmaceutical Co.,Ltd 510 participants Est. completion 2026-02 Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT06685185

    A Research Study of a New Medicine NNC0363-1063 in Healthy Participants and Participants With Type 1 Diabetes

    Not yet reported Novo Nordisk A/S 117 participants Est. completion 2026-03-18 1 site
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Active, not recruiting NCT NCT06767748

    A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin

    Not yet reported Gan & Lee Pharmaceuticals. 620 participants Est. completion 2026-02-28 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Enrolling by invitation NCT NCT06925334

    A Study Comparing Degu Insulin Liraglutide Injection With Premixed Insulin on the Prognosis of Diabetes Mellitus

    Not yet reported Beijing Tsinghua Chang Gung Hospital 170 participants Est. completion 2025-12-31 1 site Added to GLP-1
    Other conditions: Type 2 Diabetic Patients
    View official trial listing →
  • Active, not recruiting NCT NCT07018453

    A Study Comparing SHR-3167 and Insulin Degludec in Type 2 Diabetic Subjects Treated With Basal Insulin With or Without Oral Antidiabetic Drugs

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 173 participants Est. completion 2026-05 2 sites
    Type 2 diabetes
    View official trial listing →
  • Not yet recruiting NCT NCT07173712

    Regimen Transition After Short-Term Intensive Insulin Therapy in Type 2 Diabetes

    Not yet reported Yanbing Li 324 participants Est. completion 2027-12-31
    Type 2 diabetes
    View official trial listing →
  • Active, not recruiting NCT NCT07215312

    A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin

    Not yet reported Eli Lilly and Company 100 participants Est. completion 2026-12 26 sites
    Type 2 diabetes
    View official trial listing →
  • Not yet recruiting NCT NCT07387003

    Evaluate the Efficacy and Safety of GZR101-80 Injection in Patients With Type 2 Diabetes

    Not yet reported Gan & Lee Pharmaceuticals. 345 participants Est. completion 2027-09-23 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT07599891

    Comparing the Safety and Efficacy of Insulin GLARGINE and DEGLUDEC in Glucocorticoid Induced HYPERGLYCEMIA in Hospitalized Patients".

    Not yet reported Max Healthcare Insititute Limited 79 participants Est. completion 2025-03-31 1 site Stand-alone
    Other conditions: Glucocorticoid Induced Hyperglycemia
    View official trial listing →
  • Not yet recruiting NCT NCT07652528

    CGM-guided Patch Pump vs Basal-Bolus Injection for Steroid-Induced Hyperglycemia in Sudden Sensorineural Hearing Loss: SHIP Trial

    Not yet reported Hallym University 50 participants Est. completion 2028-12
    Substance use disorderType 2 diabetesPrediabetes
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Insulin Degludec, Insulin Degludec Injection

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.